If the vaccine is effective in a late-stage trial, it would be “paradigm-shifting,” one expert said.

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.

If the vaccine is effective in a late-stage trial, it would be “paradigm-shifting,” one expert said.

Patients with deadly skin cancer could soon benefit from a revolutionary vaccine that has been shown to slash the risk of their disease returning by almost half.

Dal congresso mondiale di oncologia ASCO in corso a Chicago arriva una importante conferma sull'efficacia del vaccino a mRna contro il melanoma, la cui sperimentazione è iniziata…

Leggi su Sky TG24 l'articolo Melanoma, a 5 anni vivo il 92% trattato con vaccino personalizzato

An estimated 112,000 new melanoma cases and 8,500 deaths are expected this year